Edwards Lifesciences Wins FDA Approval for PASCAL System
The FDA approved Edwards Lifesciences’ PASCAL Precision System for tricuspid valve repair, offering a new treatment option for certain patients with severe tricuspid regurgitation.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.